Tech Company Financing Transactions
One Biosciences Funding Round
One Biosciences secured a $3.8 million funding round on 9/10/2026. Backers included Bpifrance.
Transaction Overview
Company Name
Announced On
9/10/2026
Transaction Type
Venture Equity
Amount
$3,800,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding is a defining milestone for One Biosciences and the progression of single cell technology into the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 rue de Sevres
Paris, 75006
France
Paris, 75006
France
Phone
Undisclosed
Website
Email Address
Overview
One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine. Tumor heterogeneity is one of cancer's greatest challenges. We are a techbio company that brings AI-driven single-cell analysis directly into clinical practice, transforming how we understand and treat cancer. Our technology creates detailed functional profiles of patient tumors, unlocking insights that drive better clinical decision-making and accelerate precision medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ben Brahim
Chief Scientific Officer
Céline Vallot
Co-Founder
Magali Richard
Co-Founder
David Schilansky
Browse more venture capital transactions:
Prev: 9/10/2026: Heron Power venture capital transaction
Next: 9/10/2026: Vecna Robotics venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs